As of July 2026, 49 paid clinical trials are recruiting for Oncology in Newark, Delaware. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Newark has approximately 151 recruiting research studies across a wide range of therapeutic areas. Delaware hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Researchers run research studies in Newark, DE at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Helen F Graham Cancer Center | Anatomic Stage II Breast Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 61 |
| Medical Oncology Hematology Consultants PA | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma | 57 |
| Christiana Care Health System-Christiana Hospital | Stage IV Pancreatic Cancer AJCC v8, Malignant Digestive System Neoplasm, Malignant Solid Neoplasm | 27 |
| University of Delaware | Hypertension, Major Depressive Disorder, Parkinson Disease | 15 |
| Medical Oncology Hematology Consultants, PA | Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Leukemia, Myeloid, Acute | 7 |
| Christiana Care | Advanced Colorectal Cancer, Autism Spectrum Disorder, Blood Loss, Surgical | 6 |
| Medical Oncology Hematology Consultants | Advanced Malignant Neoplasm, Advanced Solid Tumor, Breast Cancer | 6 |
| Christiana Care Health Services | Advanced Cancer, Advanced or Metastatic Solid Tumor, Cardiovascular Diseases | 4 |
| Christiana Care Health Services, Inc. | Acute Myocardial Infarction, Induction of Labor Affected Fetus / Newborn, LE ALI | 3 |
| Christiana Hospital | Ischemic Stroke, Status Epilepticus | 2 |
| ChristianaCare Health System | Abnormal Uterine Bleeding, Unspecified, Adenomyosis of Uterus, Adnexal Diseases | 2 |
| ChristianaCare Helen F Graham Cancer Center and Research Institute | Carcinoma, Non-Small-Cell Lung, Multiple Myeloma | 2 |
| Medical Oncology Hematology Consultants Helen F Graham Cancer Center | Metastatic Castration-resistant Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC) | 2 |
| Medical Oncology Hematology Consultants (MOHC) | Breast Neoplasms, Lymphoma, Large B-Cell, Diffuse | 2 |
| Christiana Care Health Service | Follicular Lymphoma (FL) | 1 |
| Christiana Care Health System - Newark | Solid Tumor | 1 |
| Christiana Care Hospital | Pulmonary Embolism | 1 |
| Christiana Care Hospital - Helen F Graham Cancer Center | ALK-Positive Large B-Cell Lymphoma, Burkitt Lymphoma, Chronic Lymphocytic Leukemia | 1 |
| Christiana Care/New Castle County EMS | Congestive Heart Failure(CHF), Pulmonary Edema | 1 |
| Christiana Surgicenter | Lumbar Spinal Stenosis | 1 |
| ChristianaCare | Delivery Room Resuscitation, Implementation Research, Infant, Newborn | 1 |
| ChristianaCare Health Services, Inc. | PreTerm Neonate, Respiratory Distress Syndrome (RDS) | 1 |
| ChristianaCare-Helen F. Graham Cancer Center & Research Institute | Breast Cancer Screening, Colon Cancer Screening, Genetics Predisposition | 1 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Clinical Trial Site | Advanced Breast Cancer, Breast Cancer, ER Positive Breast Cancer | 1 |
Recruiting trials in Newark grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Delaware are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Delaware research additionally follows state public health department oversight and any applicable state privacy statutes.
Hipa.ai aggregates every recruiting study in Newark from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 151 recruiting clinical trials in Newark, Delaware listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Newark compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Newark include Breast Cancer (6), Anatomic Stage II Breast Cancer AJCC v8 (5), Multiple Myeloma (5), Stage IVB Prostate Cancer AJCC v8 (4), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Newark on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Newark include Helen F Graham Cancer Center, Medical Oncology Hematology Consultants PA, Christiana Care Health System-Christiana Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Newark are Cancer & tumors (97), Neurology & pain (8), Cardiovascular (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.